Summit Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 02/14/2025 | 24.42 M | $435.86 M | 0.00% | 3.36% |
| VANGUARD GROUP INC | 02/11/2025 | 11.67 M | $208.26 M | 6.61% | 1.61% |
| BLACKROCK, INC. | 02/07/2025 | 8.43 M | $150.46 M | 4.16% | 1.16% |
| FMR LLC | 02/13/2025 | 8.06 M | $143.75 M | -2.98% | 1.11% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 6.56 M | $117.00 M | 20.56% | 0.90% |
| STATE STREET CORP | 02/14/2025 | 5.60 M | $99.98 M | 61.54% | 0.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.20 M | $57.13 M | 3.26% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 2.05 M | $36.58 M | 67.70% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 1.49 M | $26.50 M | 3.65% | 0.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.39 M | $24.76 M | 100.64% | 0.19% |
| ABRDN PLC | 01/24/2025 | 1.29 M | $23.03 M | 13.57% | 0.18% |
| UBS GROUP AG | 02/14/2025 | 1.19 M | $21.17 M | 890.12% | 0.16% |
| TWIN TREE MANAGEMENT, LP | 02/10/2025 | 1.17 M | $20.82 M | 31.04% | 0.16% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.05 M | $18.81 M | 1.35% | 0.15% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 910,002 | $16.24 M | 83.71% | 0.13% |
| NORTHERN TRUST CORP | 02/14/2025 | 871,402 | $15.55 M | 1.64% | 0.12% |
| CANDRIAM S.C.A. | 02/07/2025 | 842,551 | $15.04 M | -0.92% | 0.12% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 837,954 | $14.95 M | 20.62% | 0.12% |
| MORGAN STANLEY | 02/14/2025 | 560,990 | $10.01 M | -2.82% | 0.08% |
| TWIN TREE MANAGEMENT, LP | 02/10/2025 | 495,782 | $8.85 M | 121.50% | 0.07% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 493,189 | $8.80 M | 100.00% | 0.07% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 478,808 | $8.55 M | 20.40% | 0.07% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 476,814 | $8.51 M | 61.29% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 431,568 | $7.70 M | 10.47% | 0.06% |
| JANE STREET GROUP, LLC | 02/14/2025 | 411,800 | $7.35 M | -39.82% | 0.06% |
| INVESCO LTD. | 02/13/2025 | 399,050 | $7.12 M | 435.67% | 0.05% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 393,100 | $7.02 M | -18.98% | 0.05% |
| JANE STREET GROUP, LLC | 02/14/2025 | 390,700 | $6.97 M | -13.27% | 0.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 387,242 | $6.91 M | -10.19% | 0.05% |
| QVT FINANCIAL LP | 02/14/2025 | 360,524 | $6.43 M | 0.00% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 333,510 | $5.95 M | 33.73% | 0.05% |
| BARCLAYS PLC | 02/13/2025 | 330,146 | $5.89 M | 32.00% | 0.05% |
| CITADEL ADVISORS LLC | 02/14/2025 | 315,300 | $5.63 M | -31.13% | 0.04% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 311,692 | $5.56 M | 187.76% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 306,800 | $5.48 M | -49.80% | 0.04% |
| E FUND MANAGEMENT CO., LTD. | 02/07/2025 | 296,299 | $5.29 M | 5.41% | 0.04% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 256,392 | $4.58 M | -0.44% | 0.04% |
| CITIGROUP INC | 02/12/2025 | 254,040 | $4.53 M | 233.67% | 0.04% |
| 02/14/2025 | 250,000 | $4.46 M | 100.00% | 0.03% | |
| CITADEL ADVISORS LLC | 02/14/2025 | 239,000 | $4.26 M | -27.00% | 0.03% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 234,426 | $4.18 M | -13.10% | 0.03% |
| TWIN TREE MANAGEMENT, LP | 02/10/2025 | 232,900 | $4.16 M | 503.37% | 0.03% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 223,418 | $3.99 M | 19.53% | 0.03% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 02/13/2025 | 219,820 | $3.92 M | 100.00% | 0.03% |
| NEO IVY CAPITAL MANAGEMENT | 02/18/2025 | 209,577 | $3.74 M | 100.00% | 0.03% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 205,337 | $3.66 M | 358.90% | 0.03% |
| PRINCIPAL FINANCIAL GROUP INC | 01/31/2025 | 205,150 | $3.66 M | 252.81% | 0.03% |
| CITADEL ADVISORS LLC | 02/14/2025 | 187,407 | $3.34 M | -71.21% | 0.03% |
| BELLEVUE GROUP AG | 02/14/2025 | 170,594 | $3.04 M | 166.16% | 0.02% |
| IVYROCK ASSET MANAGEMENT (HK) LTD | 02/12/2025 | 166,500 | $2.97 M | 100.00% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Summit Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 24.42 M
VANGUARD GROUP INC: 11.67 M
BlackRock, Inc.: 8.43 M
FMR LLC: 8.06 M
PRICE T ROWE ASSOCIATES INC /MD/: 6.56 M
STATE STREET CORP: 5.6 M
12.74% of Summit Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 105.49 M shares in the last 24 months. This purchase volume represents approximately $2.18 B in transactions.